“…Another important limitation is that the number of publications on acute rejection after SARS‐CoV‐2 vaccination exceeds by far the number of reports of keratoplasty patients developing corneal allograft rejection after other vaccines; while this is possibly due to increased awareness of the potential of immunization‐induced immune reactions on corneal grafts, it is also possible that the novelty of the viral agent and the novelty of the mRNA vaccines raised a potential publication bias. We emphasize our belief that the benefits of SARS‐CoV‐2 vaccination far outweigh the potential risks of acute corneal allograft rejection following vaccination, considering the potentially severe complications of COVID‐19 disease, and considering the potential ocular manifestations of COVID‐19 (Cunha et al, 2020 ), which may also include acute corneal graft rejection (Ang et al, 2020 ; Behera et al, 2021 ; Jin & Juthani, 2020 ; Singh & Mathur, 2021 ). Most corneal surgeons agree with this policy, according to a recent survey of 142 corneal surgeons (Lockington et al, 2021 ).…”